Adivo
Adivo is passionate about developing new technologies to expand the range of therapeutic options for veterinarians and pet owners for their companions.
Employees
Company register number
HRB 240037 (München)
loading funding rounds…
High-Tech Gründerfonds(exited)
MorphoSys(exited)
European Innovation Council(exited)
OCCIDENT – The Science Investor.(exited)
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
More about Adivo
EditDeveloper of species-specific therapeutic antibodies intended to meet the medical need of pets. The company creates antibodies for companion animals and it develops technologies to expand the range of therapeutic options for pet cancer and chronic inflammatory conditions, enabling veterinarians and pet owners to have specific treatment options available for their pets.
Keywords: Pharmaceuticals and Biotechnology, Chronic Inflammatory, Pet Cancer, Pet Therapeutic Product, Pet Therapeutics, Phage Display, Therapeutic Antibodies.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.